Neural tube defect genes and maternal diabetes during pregnancy

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 8, 2010, Pages 601-611

  Salbaum, J Michael ^a   Kappen, Claudia ^b  

^a Laboratory of Regulation of Gene Expression   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Epigenetic modifications; Gene expression; Incomplete penetrance; Signaling pathways; Variability

Indexed keywords

TERATOGENIC AGENT;

ACCURACY; ARTICLE; CHROMATIN; EMBRYO DEVELOPMENT; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME; HUMAN; MATERNAL DIABETES MELLITUS; MICROARRAY ANALYSIS; NEURAL TUBE DEFECT; PENETRANCE; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL;

ANIMALS; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VARIATION; HUMANS; KIDNEY; MICE; NEURAL TUBE DEFECTS; PLACENTA; PREGNANCY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

RODENTIA;

EID: 77955595308     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20680     Document Type: Article

References (41)

1. Aberg A, Westbom L, Kallen B, et al. 2001. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61:85-95.
2. Baelde HJ, Eikmans M, Doran PP, et al. 2004. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43:636-650.
3. Casson IF, Clarke CA, Howard CV, et al. 1997. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275-278.
4. Chan BW, Chan KS, Koide T, et al. 2002. Maternal diabetes increases the risk of caudal regression caused by retinoic acid. Diabetes 51:2811-2816.
5. Chang TI, Loeken MR. 1999. Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis. Semin Reprod Endocrinol 17:153-165.
6. Chappell JH Jr, Wang XD, Loeken MR. 2009. Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis 14:1472-1483.
7. Davison JM, Mellott TJ, Kovacheva VP, et al. 2009. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem 284:1982-1989.
8. Dunne F. 2005. Type 2 diabetes and pregnancy. Semin Fetal Neonatal Med 10(4):333-339.
9. Fraser FC. 1980. The William Allan Memorial Award Address: evolution of a palatable multifactorial threshold model. Am J Hum Genet 32:796-813.
10. Goto MP, Goldman AS. 1994. Diabetic embryopathy. Curr Opin Pediatr 6:486-491.
11. Greene MF. 1999. Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol 17:127-136.
12. Greene MF. 2001. Diabetic embryopathy 2001: moving beyond the "diabetic milieu." Teratology 63:116-118.
13. Grüneberg H. 1952a. Genetical studies on the skeleton of the mouse. IV. Quasi-continuous variations. J Genet 51:95-114.
14. Grüneberg H. 1952b. The genetics of the mouse. The Hague: Martinus Nijhoff.
15. Harris MJ, Juriloff DM. 2007. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol 79:187-210.
16. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
17. Jiang B, Kumar SD, Loh WT, et al. 2008. Global gene expression analysis of cranial neural tubes in embryos of diabetic mice. J Neurosci Res 86:3481-3493.
18. Kappen C, Pavlinkova G, Kruger C, Salbaum JM. 2010. Analysis of altered gene expression in diabetic embryopathy. In: McQueen CA, editor. Comprehensive toxicology. 2nd ed. Oxford: Elsevier.
19. Knox K, Baker JC. 2008. Genomic evolution of the placenta using cooption and duplication and divergence. Genome Res 18:695-705.
20. Kruger C, Kappen C. 2010. Microarray analysis of defective cartilage in Hoxc8- and Hoxd4-transgenic mice. Cartilage; first published online March 22, 2010. doi: 10.1177/1947603510363005.
21. Kucera J. 1971. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:73-82.
22. Kumar SD, Dheen ST, Tay SS, et al. 2007. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 6:34.
23. Lin W, Zhang Z, Srajer G, et al. 2008. Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev Dyn 237:928-940. (Pubitemid 351542291)
24. Loeken MR. 2008. Challenges in understanding diabetic embryopathy. Diabetes 57:3187-3188.
25. Loots GG, Ovcharenko I. 2004. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 32(Web Server issue):W217-W221.
26. Machado AF, Zimmerman EF, Hovland DN, et al. 2001. Diabetic embryopathy in C57BL/6J mice: altered fetal sex ratio and impact of the splotch allele. Diabetes 50:1193-1199.
27. Martinez-Frias ML. 1994. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51:108-113.
28. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, et al. 1998. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 78:140-145.
29. Mills JL. 1982. Malformations in infants of diabetic mothers. Teratology 25:385-394.
30. National Diabetes Data Group. 1995. Diabetes in America. 2nd ed. NIH Publication No. 95-1468. Bethesda, MD: National Institutes of Health.
31. Otani H, Tanaka O, Tatewaki R, et al. 1991. Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40:1245-1250.
32. Pavlinkova G, Salbaum JM, Kappen C. 2009. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genomics 10:274.
33. Pavlinkova G, Salbaum JM, Kappen C, et al. 2008. Wnt signaling in caudal dysgenesis and diabetic embryopathy. Birth Defects Res A Clin Mol Teratol 82:710-719.
34. Phelan SA, Ito M, Loeken MR, et al. 1997. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197.
35. Reece EA, Ji I, Wu YK, et al. 2006. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis. Am J Obstet Gynecol 195:1075-1080.
36. Tachibana M, Sugimoto K, Nozaki M, et al. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16:1779-1791.
37. Visel A, Blow MJ, Li Z, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457:854-858.
38. Wagschal A, Sutherland HG, Woodfine K, et al. 2008. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol 28:1104-1113.
39. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293-5300.
40. Wellen KE, Hatzivassiliou G, Sachdeva UM, et al. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076-1080.
41. Yamauchi T, Yamauchi J, Kuwata T, et al. 2000. Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci USA 97:11303-11306.